Peptide & Oligo CDMO Services
Research Peptides
CPC Scientific is one of the premier custom peptide producers in the world and we are proud to offer consistently reliable, high-quality peptides directly to researchers.
GMP Peptides
Large-scale manufacturing capacity to support your GMP projects at every stage, from early discovery and late-phase development to full commercialization.
Oligonucleotides
We provide research-grade and clinical-grade oligonucleotide manufacturing services to our clients spanning from discovery to clinical phases.
Peptide-Oligo Conjugates
Our peptide-oligonucleotide conjugate (POC) services seamlessly integrate our peptide and oligonucleotide platforms.
Trusted Peptide & Oligo Manufacturer
With 25 years of expertise, our group is a globally recognized and leading CDMO specializing in peptide and oligonucleotide production. We work directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market.
300+
NCE & Generic Projects
13
Commercial GMP Projects
>1T
Annual Production Capacity
Featured News & Articles
Recent Publications and Citations
Nakagawa, Mayumi. U.S. Patent Application No. 14/566,604, filed August 13, 2015.
“To define the minimal and optimal amino acids sequences of the CD8 T-cell epitope, 8-mer, 10-mer, 11-mer, and homologous peptides were synthesized (CPC Scientific, Inc, San Jose, Calif.)… Their safety for human use is ensured, in accordance with FDA requirements…(each peptide to be assessed individually […]
Published On: August 13th, 2015Categories: Citations, GMP Peptide ManufacturingMiles, Linde A., et al. PloS One 10.6 (2015): e0129103.
"Peptides corresponding to the substrate sequences L/VP4.1 and non-hydrolysable linker (NHL) were synthesized between a 5-carboxyfluorescein (5-FAM) fluorophore/CPC Quencher (CPQ2) quencher pair (CPC Scientific). Additional lysines were added for increased solubility giving final peptide sequences of CPQ2-IVYELQGP-K(5FAM)-KK-NH2 and CPQ2-GGSGGS-K(5FAM)-KK-NH2 for L/VP4.1 and NHL, respectively. The identity and sequence of the L/VP4.1 and NHL peptides were confirmed by CPC Scientific via LC-MS and determined to be 96.7% and 95.1% pure, respectively."
Published On: June 12th, 2015Categories: Citations, Dye-Labeled, FRET SubstratesMaegley, K.A., Krivacic, C., Bingham, P., Liu, W. and Brooun, A. ASSAY and Drug Development Technologies 13, no. 4 (2015): 235-240.
- Oncology Research Unit and 2 Oncology Medicinal Chemistry, Pfizer World Wide Research and Development, San Diego, California.
MS solvents were purchased from Sigma and Burdick & Jackson. Custom peptides were synthesized by CPC Scientific.
Published On: June 12th, 2015Categories: Citations
What Clients Say About Working With CPC Scientific
CPC Scientific has been our trusted provider of high-quality APIs for several years, consistently delivering exceptional reliability, technical expertise, and quality. Their contribution was instrumental in advancing a life-saving therapy. As a European biotech company, we rely on CPC Scientific’s expertise and dedication to support our long-term success.
CEO, Boutique European Biotechnology Company
CPC Scientific has been an essential CDMO partner throughout our peptide development journey, consistently delivering reliable, high-quality peptides. As a small Brazilian biotech focused on specialized disease areas, we value their fairness, transparency, and seamless collaboration. Their support plays a vital role in helping us bring our innovations to life.
Founder & CEO, Mid-Sized Brazilian Biotech Company
CPC Scientific has been an invaluable CRDMO partner in our research. One representative, in particular, has consistently gone above and beyond to ensure our complex peptide orders were delivered on time, ensuring we met key deadlines for PK and efficacy studies. Their exceptional customer service, responsiveness, and industry expertise have made a significant impact on our work. Even as a relatively new client, we’ve felt fully supported. Thank you, CPC Scientific, for your support of academic drug discovery research through outstanding service!
Faculty Member, Drug Discovery Researcher, and Director of R&D, U.S.-Based Academic Institution
CPC Scientific has been our trusted provider of high-quality APIs for several years, consistently delivering exceptional reliability, technical expertise, and quality. Their contribution was instrumental in advancing a life-saving therapy. As a European biotech company, we rely on CPC Scientific’s expertise and dedication to support our long-term success.
CEO, Boutique European Biotechnology Company
CPC Scientific has been an essential CDMO partner throughout our peptide development journey, consistently delivering reliable, high-quality peptides. As a small Brazilian biotech focused on specialized disease areas, we value their fairness, transparency, and seamless collaboration. Their support plays a vital role in helping us bring our innovations to life.
Founder & CEO, Mid-Sized Brazilian Biotech Company
CPC Scientific has been an invaluable CRDMO partner in our research. One representative, in particular, has consistently gone above and beyond to ensure our complex peptide orders were delivered on time, ensuring we met key deadlines for PK and efficacy studies. Their exceptional customer service, responsiveness, and industry expertise have made a significant impact on our work. Even as a relatively new client, we’ve felt fully supported. Thank you, CPC Scientific, for your support of academic drug discovery research through outstanding service!
Faculty Member, Drug Discovery Researcher, and Director of R&D, U.S.-Based Academic Institution
Medtide Inc. Stock
Parent Company of CPC Scientific
(HKEX: 3880.HK)
Parent Company of CPC Scientific
(HKEX: 3880.HK)
